Clinical Trials Browser

Phase EARLY_PHASE1 × Pancreatic Neoplasms × Magnetic Resonance Imaging × Clear all

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Phase EARLY_PHASE1 Completed

Gastrointestinal

Pancreatic Neoplasms